Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 4, 2015
Flibanserin, made by Sprout Pharmaceuticals', prepares to face the FDA again. The drug, which may improve sexual satisfaction and the stress associated with decreased sexual desire, has been rejected twice before-- raising concerns about gender bias at the FDA